ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38535 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38535; 2) Community: the network communities that were significantly associated with the response to NSC 38535; 3) Molecule: the relationships between components within communities and NSC 38535; 4) MDR: the compounds that were significantly associated with the NSC 38535.

NSC Compound Enrichment Correlation
NSC 382006 Null 0.0286383688883671 0.78161867
NSC 100071 component of Halotex 0.0339770934764509 0.62326945
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0339770934764509 0.0012653237
NSC 1393 4-APP 0.0339770934764509 0.32928615
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0339770934764509 -0.078686278
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0339770934764509 0.19009525
NSC 24030 p-Phenylenediamine (8CI), N-butyl-N'-phenyl- 0.0339770934764509 0.26868066
NSC 245456 Naphthalene, 2,3-dimethoxy-6-(2-nitroethenyl)- 0.0339770934764509 0.36987371
NSC 266491 Psorspermin 0.0339770934764509 0.35212387
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0339770934764509 0.067146158
Total:121  Current:83    [First] [Prev] [Next] [Last]